Drug recall · April 1, 2020
Advil Liqui-Gel Mini 160+20+20 CT recall
Why: Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Advil Liqui-Gel Mini 160+20+20 CT (e-commerce) NDC # 0573-1715-59 SKU# F00573171559 (original lot # R53074) Co-packaged Batch/Lot # 0198FR & 3188FRB
- Lots / codes
Batch/Lot # Lot # 0198FR, original lot # R53074, exp. date 10/31/2020 Lot # 3188FRB, original lot # R53074, exp. date 10/31/2020
- Quantity
- 4,104 bottles
- Company
- Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ
- Distribution
- Product was distributed throughout the United States, including Puerto Rico.
- Initiated
- March 16, 2020 · Voluntary: Firm initiated
- Classified
- March 26, 2020
- Reported
- April 1, 2020
- Ended
- October 28, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.